Senators call on NIH to take action on slow-to-report clinical trial sponsors
With tens of billions in annual appropriations, a group of four Republican senators is publicly wondering why the National Institutes of Health can’t do a better job of ensuring taxpayer-funded research is published in a timely manner, they said in a letter sent last week to NIH acting director Lawrence Tabak.
The letter comes as a recent HHS inspector general report found that 72 clinical trials requiring results to be submitted in 2019 or 2020 were submitted on time, late or not submitted at all. While NIH concurred with the August report’s recommendations and said it would take steps to address them, the senators are curious as to what exactly NIH is doing on the matter.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
